test

Catherine Newcomb

@Nicholas Investment Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.09BTotal holdings218
Assets growth rate13.05%Assets growth rate (2-Q avg)5.89%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Nicholas Investment Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 218 positions.

Assets under management

The assets under management (AUM) of Nicholas Investment Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.09B in assets, with a quarterly growth rate of 13.05% and a 2-quarter average growth rate of 5.89%. The portfolio is managed by Catherine Newcomb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ACLXArcellx Inc
Recent Activity
New Position
0.29%
$3.055M
36,586 shares@ $83.52 avg price
KVYOKlaviyo Inc
Recent Activity
New Position
0.28%
$3.044M
86,046 shares@ $35.38 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
0.28%
$2.993M
117,523 shares@ $25.48 avg price
WGSGenedx Holdings Corp
Recent Activity
New Position
0.28%
$2.943M
69,337 shares@ $42.44 avg price
SPRYArs Pharmaceuticals Inc
Recent Activity
New Position
0.27%
$2.926M
201,771 shares@ $14.51 avg price
8168⤦Semtech Corp
Recent Activity
New Position
0.26%
$2.828M
2M shares@ $1.42 avg price
ASTHAstrana Health Inc
Recent Activity
New Position
0.26%
$2.789M
48,131 shares@ $57.94 avg price
AXGNAxogen Inc
Recent Activity
New Position
0.26%
$2.764M
197,135 shares@ $14.03 avg price
GKOSGlaukos Corp
Recent Activity
New Position
0.25%
$2.7M
20,724 shares@ $130.29 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.25%
$2.662M
376,014 shares@ $7.08 avg price